Carson Wealth (CWM LLC)’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$94.9K Buy
6,902
+6,685
+3,081% +$103K ﹤0.01% 3317
2025
Q4
$3K Buy
217
+191
+735% +$3.52K ﹤0.01% 5023
2025
Q3
$1K Buy
+26
New +$965 ﹤0.01% 5195
2024
Q4
Hold
0
5167
2024
Q3
Hold
0
5149

Other funds holding TNXP

Carson Wealth (CWM LLC)'s TNXP Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Tonix Pharmaceuticals (TNXP) stake by 3,081% in Q1 2026, buying an estimated $103K and bringing the position to 6,902 shares worth $94.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3317.

Carson Wealth (CWM LLC) first reported a position in TNXP in Q3 2025 and has held it in 3 quarters since. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Carson Wealth (CWM LLC) held 6,902 shares of Tonix Pharmaceuticals worth $94.9K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 6,685 Tonix Pharmaceuticals shares in Q1 2026, an estimated $103K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3317 holding.
  • Carson Wealth (CWM LLC) first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.